Author: Zhiheng Xu; Jianmeng Zhou; Yongbo Huang; Xuesong Liu; Yonghao Xu; Sibei Chen; Dongdong Liu; Zhimin Lin; Xiaoqing Liu; Yimin Li
Title: The efficacy of convalescent plasma for the treatment of severe influenza Document date: 2020_2_23
ID: 4pe9o59g_47
Snippet: For secondary outcomes, including days in ICU and hospital, and days on mechanical ventilation, 3 RCTs reported relevant data showed non-significant reductions between H-IVIG/immune plasma group and control group (14, 17, 19) . A and B (15, 18) , decreases influenza B viral loads (15) and cytokines levels in H1N1 (17), there was no clinical benefit observed in patients receiving H-IVIG/immune plasma infusion......
Document: For secondary outcomes, including days in ICU and hospital, and days on mechanical ventilation, 3 RCTs reported relevant data showed non-significant reductions between H-IVIG/immune plasma group and control group (14, 17, 19) . A and B (15, 18) , decreases influenza B viral loads (15) and cytokines levels in H1N1 (17), there was no clinical benefit observed in patients receiving H-IVIG/immune plasma infusion.
Search related documents:
Co phrase search for related documents- clinical benefit and mechanical ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical benefit and mechanical ventilation day: 1, 2, 3
- clinical benefit and non significant reduction: 1
- clinical benefit and plasma group: 1, 2
- clinical benefit and plasma infusion: 1, 2
- clinical benefit and secondary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical benefit and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- control group and cytokine level: 1, 2, 3, 4, 5
- control group and hospital ICU day: 1, 2, 3, 4, 5, 6
- control group and hospital ICU day include: 1
- control group and immune plasma group: 1
- control group and mechanical ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and mechanical ventilation day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- control group and non significant reduction: 1, 2, 3, 4, 5
- control group and plasma group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and plasma infusion: 1, 2, 3, 4, 5, 6
- control group and secondary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group immune plasma group and plasma group: 1
Co phrase search for related documents, hyperlinks ordered by date